Neuronetics director granted 30,000 RSUs
Cucuz Sasha reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Cucuz Sasha reported acquisition or exercise transactions in this Form 4 filing.
Neuronetics, Inc. director Sasha Cucuz received an award of 30,000 restricted stock units (RSUs) of common stock. The RSUs vest on the earlier of May 28, 2027 or a Board-approved separation of service or change in control, in each case requiring continuous service until that date.
Each RSU represents a contingent right to receive one share of Neuronetics common stock. Following this grant, Cucuz directly holds 1,542,798 shares. Separate indirectly held shares are reported as held by Greybrook Health Inc. (516,084 shares) and Greybrook Realty Partners Inc. (2,042 shares), with beneficial ownership of these indirect holdings disclaimed except to the extent of his pecuniary interest.
Insider Trade Summary
Grant/Award: 30,000 shares
Grant/Award
3 txns
Insider
Cucuz Sasha
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 30,000 | $0.00 | $0.00 |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 1,542,798 shares (Direct);
Common Stock — 2,042 shares (Indirect, By Greybrook Realty Partners Inc.);
Common Stock — 516,084 shares (Indirect, By Greybrook Health Inc.)
Footnotes (3)
- F1. Represents a restricted stock unit ("RSU") award that vests on the earlier of (a) May 28, 2027 or (b) the Reporting Person's Board-approved separation of service from the Issuer or change in control of the Issuer, in each case subject to continuous service of the Reporting Person through such date.
- F2. Each RSU represents a contingent right to receive one share of the Issuer's common stock.
- F3. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
Key Figures
RSU grant size: 30,000 RSUs
RSU vesting date: May 28, 2027
Direct holdings after grant: 1,542,798 shares
+3 more
6 metrics
RSU grant size
30,000 RSUs
Award to director Sasha Cucuz on May 28, 2026
RSU vesting date
May 28, 2027
Vests earlier of this date or certain board-approved events
Direct holdings after grant
1,542,798 shares
Neuronetics common stock held directly by Sasha Cucuz
Indirect holdings via Greybrook Health Inc.
516,084 shares
Neuronetics common stock held by Greybrook Health Inc.
Indirect holdings via Greybrook Realty Partners Inc.
2,042 shares
Neuronetics common stock held by Greybrook Realty Partners Inc.
RSU price per share
$0.0000 per share
Grant price for 30,000 RSUs (compensation award)
Key Terms
restricted stock unit ("RSU"), change in control, beneficial ownership, pecuniary interest, +1 more
5 terms
restricted stock unit ("RSU") financial
"Represents a restricted stock unit ("RSU") award that vests on the earlier of (a) May 28, 2027..."
change in control financial
"...or change in control of the Issuer, in each case subject to continuous service..."
A "change in control" occurs when the ownership or management of a company shifts significantly, such as through a merger, acquisition, or sale of a large part of its assets. This change can impact how the company is run and may influence its future direction. For investors, it matters because it can affect the company's stability, strategy, and value, often signaling potential changes in investment risk or opportunity.
beneficial ownership financial
"The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein..."
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
pecuniary interest financial
"...except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report..."
Section 16 regulatory
"...shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."
Section 16 is a U.S. securities law rule that governs the trading and disclosure obligations of company insiders — typically officers, directors and large shareholders — to promote transparency and deter unfair profit-taking. It requires insiders to publicly report their stock trades and allows companies or the issuer to reclaim quick, short-term profits from certain insider trades, like a scoreboard and a refund policy that help investors see and limit possible insider advantage.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Neuronetics (STIM) director Sasha Cucuz receive in this Form 4?
Sasha Cucuz received a grant of 30,000 restricted stock units (RSUs) of Neuronetics common stock. This is a compensation-related award, not an open-market purchase or sale, and each RSU will convert into one share when it vests.
When do Sasha Cucuz’s 30,000 Neuronetics (STIM) RSUs vest?
The 30,000 RSUs vest on the earlier of May 28, 2027 or a Board-approved separation of service or change in control. In each case, vesting requires continuous service by Cucuz through the applicable vesting date.
What does each Neuronetics (STIM) RSU granted to Sasha Cucuz represent?
Each restricted stock unit represents a contingent right to receive one share of Neuronetics common stock. The shares will be delivered if and when the RSUs vest under the stated conditions tied to service and potential corporate events.
How are the indirect Neuronetics (STIM) holdings attributed in this Form 4?
The filing shows 516,084 shares held by Greybrook Health Inc. and 2,042 shares held by Greybrook Realty Partners Inc. Sasha Cucuz disclaims beneficial ownership of these indirect holdings except to the extent of his pecuniary interest in those entities.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates